Drug · DIN 02238593
MUSE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 20, 2026; first marketed September 24, 1998.
- Drug Identification Number (DIN)
- 02238593
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Suppository
- Route
- Urethral
- Therapeutic class (ATC)
- Alprostadil G04BE01
- Class
- Human
- Record last updated
- May 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALPROSTADIL | 250 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 13, 2026: NOC 37530New Drug Submission (NDS) · Administrative: Change in product ownership
- May 9, 2025: NOC 35329New Drug Submission (NDS) · Update to package labels. Update to package insert. Administrative: Change in product ownership. Product Monograph reformatted to the Master Template
- June 5, 2009: NOC 10240New Drug Submission (NDS) · Manufacturer name change
- March 2, 2006: NOC 7795New Drug Submission (NDS) · Manufacturer name change
- January 9, 2001: NOC 1700New Drug Submission (NDS) · Manufacturer name change
- August 13, 1998: NOC 2671New Drug Submission (NDS)
Other DINs named MUSE
- DIN 02238592 · Cancelled Pre Market
- DIN 02238594 · Cancelled Post Market
- DIN 02238595 · Cancelled Post Market